Bank of New York Mellon Corp Has $29.82 Million Stake in ICU Medical, Inc. (NASDAQ:ICUI)

Bank of New York Mellon Corp trimmed its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 6.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 192,181 shares of the medical instruments supplier’s stock after selling 13,653 shares during the period. Bank of New York Mellon Corp owned about 0.79% of ICU Medical worth $29,821,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently modified their holdings of the company. Venturi Wealth Management LLC grew its holdings in shares of ICU Medical by 1,510.0% during the third quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier’s stock worth $59,000 after buying an additional 302 shares in the last quarter. Point72 Hong Kong Ltd bought a new position in shares of ICU Medical during the third quarter worth about $72,000. Coldstream Capital Management Inc. bought a new position in shares of ICU Medical during the third quarter worth about $227,000. OLD National Bancorp IN grew its holdings in shares of ICU Medical by 22.0% during the fourth quarter. OLD National Bancorp IN now owns 1,462 shares of the medical instruments supplier’s stock worth $227,000 after buying an additional 264 shares in the last quarter. Finally, Atria Investments Inc bought a new position in shares of ICU Medical during the third quarter worth about $228,000. 96.10% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of the firm’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total transaction of $213,474.04. Following the transaction, the chief executive officer now owns 104,593 shares in the company, valued at $16,262,119.64. This trade represents a 1.30 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 6.70% of the stock is currently owned by insiders.

ICU Medical Stock Down 0.2 %

ICUI stock opened at $141.97 on Friday. ICU Medical, Inc. has a twelve month low of $93.36 and a twelve month high of $196.26. The company has a market cap of $3.48 billion, a price-to-earnings ratio of -31.07 and a beta of 0.73. The business has a 50 day moving average price of $159.04 and a two-hundred day moving average price of $165.74. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on ICUI. StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, November 20th. Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. KeyCorp raised their price target on ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research note on Wednesday, November 13th. Finally, Jefferies Financial Group upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target for the company in a research note on Wednesday, December 11th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, ICU Medical has an average rating of “Moderate Buy” and a consensus target price of $199.67.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.